Last reviewed · How we verify
Real World Evidence Clinical Utility Study of KidneyIntelX
The purpose of this study is to assess the impact of the KidneyIntelX assay utilized as part of the current standard of care on the management of patients seen in the primary care physician's office at Mount Sinai.
Details
| Lead sponsor | Renalytix AI, Inc. |
|---|---|
| Status | RECRUITING |
| Enrolment | 10000 |
| Start date | Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Dec 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Chronic Kidney Diseases
- Diabetic Kidney Disease
Interventions
- KidneyIntelX
Countries
United States